Perinatally acquired human immunodeficiency virus infection in infants: updated guidelines for prevention, diagnosis, and initiation of treatment.
Perinatally acquired human immunodeficiency virus (HIV) infection can be prevented through education and, for women with HIV and their babies, administration of chemoprophylaxis during the perinatal period. When perinatally acquired HIV infection occurs, early intervention can promote the quality and duration of the infant's life. This report updates and consolidates current recommendations related to the prevention of perinatally acquired HIV infection, as well as recommendations for the management of perinatally exposed and infected infants through the first year of life.
Santacroce
S
S
Center for Advancing Care in Serious Illness, School of Nursing, University of Pennsylvania, 420 Guardian Dr, Nursing Education Building, Room 2U2011, Philadelphia, PA 19104-6096, USA.
Vincent
C
C
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009722:Nurse Practitioners / Q000592:standards*; D017410:Practice Guidelines as Topic; D011247:Pregnancy
D019380:Anti-HIV Agents